Use of Ferritin-Based Metal-Encapsulated Nanocarriers as Anticancer Agents
Source abstract
Abstract
The ability of ferritin to bind and deliver metals and metal-based drugs to human neuroblastoma SH-SY5Y cells was studied. We used heavy chain (H) ferritin-based metal-containing nanocarriers to test whether these constructs, which are able to cross the blood-brain barrier, may be used for the delivery of toxic molecules to brain cells, and to study their effect on the viability and cellular redox homeostasis of human neuroblastoma cells. We show that metal-containing nanocarriers are efficiently captured by SH-SY5Y cells. Iron-containing nanocarriers have a proliferative effect, while silver and cisplatin-encapsulated nanocarriers determine concentration-dependent neuroblastoma cell death. This work is a proof of concept for the use of ferritins for the delivery of toxic molecules to brain tumors.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Iron Metabolism and Disorders · Nanoparticle-Based Drug Delivery · Trace Elements in Health
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemical Sciences, Sapienza University, 00185 Rome, Italy
IBPM CNR, Institute of Molecular Biology and Pathology, Italian National Research Council, 00185 Rome, Italy
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC)
References (56)
Show source-provided references
1. Delivering nanomedicine to solid tumors10.1038/nrclinonc.2010.139 ↗
2. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics10.1016/j.biomaterials.2013.07.049 ↗
3. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe10.1158/0008-5472.CAN-06-1728 ↗
4. Ferritin: A versatile building block for bionanotechnology10.1021/cr400011b ↗
5. Electrostatic assembly of binary nanoparticle superlattices using protein cages10.1038/nnano.2012.220 ↗
6. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection10.1073/pnas.1407808111 ↗
7. Chimeric ferritin nanocages for multiple function loading and multimodal imaging10.1021/nl104141g ↗
8. Functionalization of protein-based nanocages for drug delivery applications10.1039/C4NR00915K ↗
9. Intracellular distribution of macrophage targeting ferritin-iron oxide nanocomposite10.1002/adma.200801209 ↗
10. Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements10.1021/acs.biomac.5b01446 ↗
11. Silver ion incorporation and nanoparticle formation inside the cavity of Pyrococcus furiosus ferritin: Structural and size-distribution analyses10.1021/ja910918b ↗
12. The ferritins: molecular properties, iron storage function and cellular regulation10.1016/0005-2728(96)00022-9 ↗
13. The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers10.1006/jmbi.1994.1325 ↗
14. Early embryonic lethality of H ferritin gene deletion in mice10.1074/jbc.275.5.3021 ↗
15. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress10.1002/jnr.10463 ↗
16. Iron and proteins for iron storage and detoxification10.1023/B:BIOM.0000027692.24395.76 ↗
17. Influence of site-directed modifications on the formation of iron cores in ferritin10.1016/0022-2836(91)90944-2 ↗
18. Ferritin: A novel mechanism for delivery of iron to the brain and other organs10.1152/ajpcell.00599.2006 ↗
19. Receptor-mediated transcytosis of transferrin across the blood-brain barrier10.1002/jnr.490180206 ↗
20. Transferrin receptor on endothelium of brain capillaries10.1038/312162a0 ↗
21. Brain microvasculature in aging10.1016/0197-4580(94)90063-9 ↗
22. Binding and uptake of H-ferritin are mediated by human transferrin receptor-110.1073/pnas.0913192107 ↗
23. Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain10.1016/S0022-510X(99)00203-8 ↗
24. Transferrin receptor-mediated endocytosis: A useful target for cancer therapy10.1007/s00232-014-9637-0 ↗
25. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin10.1039/c3nr04268e ↗
26. Inhibitory effect of silver nanoparticles on trypanothione reductase activity and leishmania infantum proliferation10.1021/ml1002629 ↗
27. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells10.1016/j.jconrel.2014.10.002 ↗
28. Synthesis of iron oxide nanoparticles in Listeria innocua Dps (DNA-binding protein from starved cells): A study with the wild-type protein and a catalytic centre mutant10.1002/chem.200901138 ↗
29. A smart platform for hyperthermia application in cancer treatment: Cobalt-doped ferrite nanoparticles mineralized in human ferritin cages10.1021/nn500454n ↗
30. In vivo targeting of cutaneous melanoma using an melanoma stimulating hormone-engineered human protein cage with fluorophore and magnetic resonance imaging tracers10.1166/jbn.2015.1946 ↗
31. Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes10.1016/j.brainres.2008.09.012 ↗
32. Transferrin receptors in human tissues: their distribution and possible clinical relevance10.1136/jcp.36.5.539 ↗
33. Transferrin receptor 2 is frequently expressed in human cancer cell lines10.1016/j.bcmd.2007.02.003 ↗
34. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis10.1378/chest.97.6.1367 ↗
35. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer10.1016/j.canlet.2005.07.001 ↗
36. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas10.1016/j.ejca.2004.01.036 ↗
37. Transferrin receptor expression by human bladder transitional cell carcinomas10.1007/BF00265663 ↗
38. Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma10.1097/PAI.0b013e318209716e ↗
39. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells10.1007/s11095-011-0624-1 ↗
40. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes10.1016/j.jconrel.2006.02.011 ↗
41. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats
42. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery10.1016/j.ijpharm.2013.09.021 ↗
43. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil
44. Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins10.1016/j.jconrel.2008.10.006 ↗
45. Sakamoto, S., Kawabata, H., Masuda, T., Uchiyama, T., Mizumoto, C., Ohmori, K., Koeffler, H.P., Kadowaki, N., and Takaori-Kondo, A. (2015). H-ferritin is preferentially incorporated by human erythroid cells through transferrin receptor 1 in a threshold-dependent manner. PLoS ONE, 10.10.1371/journal.pone.0139915 ↗
46. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE10.1096/fj.06-6397com ↗
47. Sodium ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake10.1186/1476-4598-6-55 ↗
48. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells
49. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier10.1146/annurev-pharmtox-010814-124852 ↗
50. Metals and metal derivatives in medicine
51. In vitro cytotoxicities and in vivo distribution of transferrin-platinum(II) complex10.1002/jps.2600840219 ↗
52. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation10.1021/pr100457n ↗
53. Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-1610.3892/or.2013.2731 ↗
54. Asharani, P.V., Hande, M.P., and Valiyaveettil, S. (2009). Anti-proliferative activity of silver nanoparticles. BMC Cell Biol., 10.10.1186/1471-2121-10-65 ↗
55. Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells10.1155/2014/259765 ↗
56. Neuroprotective effect of brassica oleracea sprouts crude juice in a cellular model of alzheimer’s disease10.1155/2015/781938 ↗